TransMedics (TMDX) FCF Margin (QoQ) (2018 - 2026)
TransMedics (TMDX) FCF Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.62 Bn | 197.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.01 Bn | 123.54 Bn | 4.50 Bn |
| 3 | Medtronic | 119.39 Bn | 110.17 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.56 Bn | 74.02 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.82 Bn | 47.57 Bn | 1.35 Bn |
| 6 | Dexcom | 34.98 Bn | 33.03 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.26 Bn | 22.94 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | TransMedics | 3.26 Bn | 2.79 Bn | 113.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,235.00 |
| Mar 31, 2026 | -1,879.00 |
| Dec 31, 2025 | -615.00 |
| Sep 30, 2025 | -5,742.00 |
| Jun 30, 2025 | 9,622.00 |
| Mar 31, 2025 | -13,236.00 |
| Dec 31, 2024 | 21,199.00 |
| Sep 30, 2024 | -16,158.00 |
| Jun 30, 2024 | 11,028.00 |
| Mar 31, 2024 | 12,761.00 |
| Dec 31, 2023 | -16,645.00 |
| Sep 30, 2023 | -88.00 |
| Jun 30, 2023 | 1,364.00 |
| Mar 31, 2023 | -140.00 |
| Dec 31, 2022 | 6,437.00 |
| Sep 30, 2022 | -3,984.00 |
| Jun 30, 2022 | 7,561.00 |
| Mar 31, 2022 | -684.00 |
| Dec 31, 2021 | 6,042.00 |
| Sep 30, 2021 | -10,846.00 |